Diagnostic Performance of 68Ga PSMA PET CT to Detect Significant Prostate Cancer and Comparison with 18F Choline PET CT - Manuela Hoffmann


Radiolabeled prostate-specific membrane antigen (PSMA) has proven as a highly accurate method to detect recurrences and metastases of prostate cancer, but there are only sparse data about its diagnostic performance in primary prostate cancer. Manuela Hoffman presents a retrospective study of the diagnostic performance of 68Ga-PSMA PET/CT to detect significant prostate cancer in comparison with 18F-Choline PET/CT.

Biography:

Manuela Hoffman, Bundeswehr Medical Service Headquarters Koblenz Germany, Department of Nuclear Medicine, Bundeswehrzentralkrankenhaus Koblenz Germany, Department of Nuclear Medicine, Johannes Gutenberg-University Mainz Germany

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe